May 05, 2011 09:08 ET

Antibacterials Market to Shrink 2% Annually Through 2019

ROCKVILLE, MD--(Marketwire - May 5, 2011) - has announced the addition of Datamonitor's new report "Forecast Insight: Antibacterials" to their collection of Pharmaceuticals market reports. For more information, visit

Over the next decade, the fragmented antibacterials market will shift away from a blockbuster-business model, as generic erosion of market leaders and increased competition between new hospital drugs will trigger a decline in sales of branded antibacterials. While there is a lack of innovation with regards to new community drugs, the hospital sector will remain the only notable source of growth.

In 2009, antibacterial sales in the seven major markets totaled $19.6bn, declining at a compound annual growth rate (CAGR) of -1.6% since 2005. This decline was largely caused by generic erosion of market-leading community brands, such as Zithromax and Klacid, combined with a paucity of new product launches.

Over the next decade, genericization of key brands will drive a significant decline in market value, contributing to a loss of revenues from Levaquin/Cravit/Tavanic, Zosyn/Tazocin, and Zyvox alone of $3.2bn by 2019. Combined with growing resistance, this will cause increasing market fragmentation and reduce the potential for "blockbuster" sales.

The late-stage pipeline, much of which is targeting MRSA, will generate revenues totaling nearly $2.0bn by 2019. However, Datamonitor predicts that this upside will be insufficient to offset the decline caused by genericization, and total seven major market sales will fall from $19.6bn in 2009 to $16.4bn in 2019, with a CAGR of -1.8%.

For more information, visit

About is the leading provider of global market intelligence products and services. With over 300,000 research reports from more than 700 top consulting and advisory firms, offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. For more information, call Veronica Franco at 240-747-3016 or visit

Contact Information

  • Contact:
    Veronica Franco
    Email Contact